Clinical Trial Update: Inhaled Nebulised S(+)-Ketamine for Postoperative Analgesia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial of inhaled nebulised S(+)-ketamine for postoperative analgesia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain Postoperative

Drugs mentioned

• Inhaled nebulised S(+)-Ketamine (S(+)-Ketamine)

Snippet

Sponsor: Tampere University Hospital | Conditions: Pain, Postoperative | Phase 4 | Status: WITHDRAWN